72
Views
12
CrossRef citations to date
0
Altmetric
Original Articles

Apoptosis Induced by Niacin-Related Compounds in K562 Cells but not in Normal Human Lymphocytes

, , , , &
Pages 1142-1146 | Received 18 Oct 1999, Accepted 20 Jan 2000, Published online: 22 May 2014

  • 1) Kerr, J. F., Wyllie, A. H., and Currie, A. R., Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Brit. J. Cancer, 26, 239-257 (1972).
  • 2) Cohen, G. M., Caspases: the executioners of apoptosis. Biochem. J., 326, 1-16 (1997).
  • 3) Lazebnik, Y. A., Kaufmann, S. H., Desnoyers, S., Poirier, G. G., and Earnshaw, W. C., Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature, 371, 346-347 (1994).
  • 4) Shiokawa, D., Maruta, H., and Tanuma, S., Inhibitors of poly(ADP-ribose) polymerase suppress nuclear fragmentation and apoptotic-body formation during apoptosis in HL-60 cells. FEBS Lett., 413, 99-103 (1997).
  • . 1989.
  • . 1992.
  • 7) Svedmyr, N., Harthon, L., and Lundholm, L., The relationship between the plasma concentration of free nicotinic acid and some of its pharmacologic effects in man. Clin. Pharmacol. Ther., 10, 559-570 (1969).
  • 8) Dulin, W. E. and Wyse, M., Reversal of streptozotocin diabetes with nicotinamide. Proc. Soc. Exp. Biol. Med., 130, 992-994 (1969).
  • 9) Ogata, S., Okumura, K., and Taguchi, H., The effects of niacin on DNA repair after N-methyl-N′-nitro-N-nitrosoguanidine treatment in normal human lymphocytes. Biosci. Biotechnol. Biochem., 61, 2116-2118 (1997).
  • 10) Ogata, S., Takeuchi, M., Okumura, K., and Taguchi, H., Apoptosis induced by niacin-related compounds in HL-60 cells. Biosci. Biotechnol. Biochem., 62, 2351-2356 (1998).
  • 11) Hockenbery, D. M., Oltvai, Z. N., Yin, X. M., Milliman, C. L., and Korsmeyer, S. J., Bcl-2 functions in an antioxidant pathway to prevent apoptosis., Cell, 75, 241-51 (1993).
  • 12) Barbieri, D., Grassilli, E., Monti, D., Salvioli, S., Franceschini, M. G., Franchini, A., and Bellesia, E., D-ribose and deoxy-D-ribose induce apoptosis in human quiescent peripheral blood mononuclear cells. Biochem. Biophys. Res. Commun., 201, 1109-1116 (1994).
  • 13) Martins, L. M., Mesner, P. W., Kottke, T. J., Basi, G. S., Sinha, S., Tung, J. S., Svingen, P. A., Madden, B. J., Takahashi, A., McCormick, D. J., and Earnshaw, W. C., Kaufmann, S. H., Comparison of caspase activation and subcellular localization in HL-60 and K562 cells undergoing etoposide-induced apoptosis. Blood, 90, 4238-4296 (1997).
  • 14) Lozzio, C. B. and Lozzio, B. B., Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood, 45, 321-324 (1975).
  • 15) Amarante-Mendes, G. P., Naekyung Kim, C., Liu, L., Huang, Y., Perkins, C. L., Green, D. R., and Bhalla, K., Bcr-Abl exerts its antiapoptotic effect against diverse apoptotic stimuli through blockage of mitochondrial release of cytochrome C and activation of caspase-3. Blood, 91, 1700-1705 (1998).
  • 16) Wagner, B. A., Buettner,G. R., Oberley, L. W., and Burns, C. P., Sensitivity of K562 and HL-60 cells to edelfosine, an ether lipid drug, correlates with production of reactive oxygen species. Cancer Res., 58, 2809-2816 (1998).
  • 17) McGowan, A. J., Bowie, A. G., O′ Neill, L. A., and Cotter, T. G., The production of a reactive oxygen intermediate during the induction of apoptosis by cytotoxic insult. Exp. Cell Res., 238, 248-256 (1998).
  • 18) Marini, M., Frabetti, F., Brunelli, M. A., and Raggi, M. A., Inhibition of poly(ADP-ribose) polymerization preserves the glutathione pool and reverses cytotoxicity in hydrogen peroxide-treated lymphocytes. Biochem. Pharmacol., 46, 2139-2144 (1993).
  • 19) Evans, G. W. and Johnson, E. C., Growth stimulating effect of picolinic acid added to rat diets. Proc. Soc. Exp. Biol. Med., 165, 457-461 (1980).
  • 20) Melillo, G., Cox, G. W., Radzioch, D., and Varesio, L., Picolinic acid, a catabolite of L-tryptophan, is a costimulus for the induction of reactive nitrogen intermediate production in murine macrophages. J. Immunol., 150, 4031-4040 (1993).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.